Patrick Bastek Senior Director for Gene Therapy Process DevelopmentPfizerPatrick Bastek is Sr. Director for Gene Therapy Process Development at Pfizer where he leads teams to develop drug substance manufacturing processes. The team develops and transfers processes and technologies to enable clinical and commercial-scale manufacturing while seeking to increase productivity and consistency to enable this emerging modality. Prior to joining Pfizer, Patrick worked at Novartis Vaccines (then Seqirus) developing, establishing, and improving cell-based influenza manufacturing. Patrick had increasing responsibilities building and leading a Manufacturing Sciences team to build, validate, and license a greenfield facility, directing and implementing a next generation process improvement effort to significantly improve productivity, and serving as the Global Head of Technical Development across all influenza platforms for Seqirus. Prior to that Patrick held various roles in process development and contract manufacturing at Dendreon, Wyeth, and Abbott.